AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2011
Jun 20, 2011
31721_dirs_2011-06-20_f02ba624-0340-47cc-a2fd-34b42402e6ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2011-06-20
Reporting Person: Kaye Edward M. MD (Sr VP & Chief Medical Officer)
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24